Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation
Clinical trial NCT00080236 · COMPLETED
Trial details
- NCT number
- NCT00080236
- Sponsor
- Conatus Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
- Primary completion
- 2006-01-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.